Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: Candida Auris; Myopia; Covid
Testing by a team of researchers with the Louis Stokes Cleveland VA Medical Center indicates that sporicidal disinfectants are more effective against the multidrug-resistant fungal pathogen Candida auris than quaternary-ammonium disinfectants, according to a study published today in Infection Control & Hospital Epidemiology. (Dall, 8/2)
The first randomized controlled trial of its kind aimed at identifying an effective way to manage myopia was published last week. (Vanderbilt University Medical Center, 8/1)
Today, a Brown University鈥搇ed team reports聽in JAMA Network Open that older people are at lower risk of adverse events after receipt of the Moderna COVID-19 vaccine than the Pfizer/BioNTech version but emphasizes that the overall risk is very low with both mRNA vaccines. The Moderna vaccine was also tied to a 14% lower risk of contracting COVID-19 in this age-group. (Van Beusekom, 8/2)
Researchers have identified a protein biomarker that appears to protect against severe COVID-19 in people with obesity. (Van Beusekom, 7/27)
